Axcelis dominates the Ion Implanter for Power Devices segment with 70-80% share.Negative revisions, China and EV exposure caused the multiple to compress since Aug-23, in contracts to the rest.With an...
Source LinkAxcelis dominates the Ion Implanter for Power Devices segment with 70-80% share.Negative revisions, China and EV exposure caused the multiple to compress since Aug-23, in contracts to the rest.With an...
Source Link
Comments